Logo image of CLDT

CHATHAM LODGING TRUST (CLDT) Stock Fundamental Analysis

NYSE:CLDT - New York Stock Exchange, Inc. - US16208T1025 - REIT - Currency: USD

8.11  -0.19 (-2.29%)

After market: 8.11 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CLDT. CLDT was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of CLDT have multiple concerns. CLDT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CLDT had negative earnings in the past year.
CLDT had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLDT reported negative net income in multiple years.
Of the past 5 years CLDT 4 years had a positive operating cash flow.
CLDT Yearly Net Income VS EBIT VS OCF VS FCFCLDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

The Return On Assets of CLDT (-0.86%) is worse than 69.05% of its industry peers.
Looking at the Return On Equity, with a value of -1.46%, CLDT is doing worse than 65.08% of the companies in the same industry.
CLDT has a Return On Invested Capital of 2.02%. This is in the lower half of the industry: CLDT underperforms 69.05% of its industry peers.
Industry RankSector Rank
ROA -0.86%
ROE -1.46%
ROIC 2.02%
ROA(3y)-0.61%
ROA(5y)-1.22%
ROE(3y)-1.09%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A
CLDT Yearly ROA, ROE, ROICCLDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5 -10

1.3 Margins

CLDT has a Operating Margin of 10.05%. This is amonst the worse of the industry: CLDT underperforms 81.75% of its industry peers.
CLDT's Operating Margin has declined in the last couple of years.
The Gross Margin of CLDT (75.69%) is better than 73.02% of its industry peers.
In the last couple of years the Gross Margin of CLDT has remained more or less at the same level.
Industry RankSector Rank
OM 10.05%
PM (TTM) N/A
GM 75.69%
OM growth 3YN/A
OM growth 5Y-9.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y0.32%
CLDT Yearly Profit, Operating, Gross MarginsCLDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

CLDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CLDT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLDT has been increased compared to 5 years ago.
The debt/assets ratio for CLDT is higher compared to a year ago.
CLDT Yearly Shares OutstandingCLDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CLDT Yearly Total Debt VS Total AssetsCLDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B

2.2 Solvency

CLDT has an Altman-Z score of 0.44. This is a bad value and indicates that CLDT is not financially healthy and even has some risk of bankruptcy.
CLDT has a Altman-Z score of 0.44. This is comparable to the rest of the industry: CLDT outperforms 41.27% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that CLDT is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.57, CLDT belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 0.44
ROIC/WACC0.29
WACC7.06%
CLDT Yearly LT Debt VS Equity VS FCFCLDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.49 indicates that CLDT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.49, CLDT is doing worse than 83.33% of the companies in the same industry.
CLDT has a Quick Ratio of 0.49. This is a bad value and indicates that CLDT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.49, CLDT is doing worse than 79.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.49
CLDT Yearly Current Assets VS Current LiabilitesCLDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

2

3. Growth

3.1 Past

CLDT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -425.00%.
The Revenue has been growing slightly by 1.69% in the past year.
CLDT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.82% yearly.
EPS 1Y (TTM)-425%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y29.01%
Revenue growth 5Y-0.82%
Sales Q2Q%0.5%

3.2 Future

Based on estimates for the next years, CLDT will show a very negative growth in Earnings Per Share. The EPS will decrease by -249.86% on average per year.
CLDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.87% yearly.
EPS Next Y-1328%
EPS Next 2Y-249.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.43%
Revenue Next 2Y3.13%
Revenue Next 3Y2.87%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLDT Yearly Revenue VS EstimatesCLDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CLDT Yearly EPS VS EstimatesCLDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLDT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLDT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLDT Price Earnings VS Forward Price EarningsCLDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

90.48% of the companies in the same industry are more expensive than CLDT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.89
CLDT Per share dataCLDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as CLDT's earnings are expected to decrease with -249.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-249.86%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

CLDT has a Yearly Dividend Yield of 3.37%.
CLDT's Dividend Yield is slightly below the industry average, which is at 18.40.
Compared to an average S&P500 Dividend Yield of 2.27, CLDT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

The dividend of CLDT decreases each year by -19.48%.
CLDT has been paying a dividend for at least 10 years, so it has a reliable track record.
CLDT has decreased its dividend recently.
Dividend Growth(5Y)-19.48%
Div Incr Years1
Div Non Decr Years1
CLDT Yearly Dividends per shareCLDT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of CLDT are negative and hence is the payout ratio. CLDT will probably not be able to sustain this dividend level.
CLDT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-199.96%
EPS Next 2Y-249.86%
EPS Next 3YN/A
CLDT Yearly Income VS Free CF VS DividendCLDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

More info and screens

CHATHAM LODGING TRUST

NYSE:CLDT (2/21/2025, 8:09:57 PM)

After market: 8.11 0 (0%)

8.11

-0.19 (-2.29%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-26 2025-02-26/bmo
Inst Owners90.03%
Inst Owner Change-97.28%
Ins Owners2.61%
Ins Owner Change4.71%
Market Cap396.66M
Analysts80
Price Target11.48 (41.55%)
Short Float %1.02%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend0.45
Dividend Growth(5Y)-19.48%
DP-199.96%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)63.4%
Min EPS beat(2)63.4%
Max EPS beat(2)63.4%
EPS beat(4)4
Avg EPS beat(4)38.81%
Min EPS beat(4)8.09%
Max EPS beat(4)63.4%
EPS beat(8)7
Avg EPS beat(8)30.12%
EPS beat(12)10
Avg EPS beat(12)153.6%
EPS beat(16)14
Avg EPS beat(16)126.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-1.11%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.63%
Max Revenue beat(4)0.24%
Revenue beat(8)3
Avg Revenue beat(8)-0.69%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.79%
PT rev (1m)0.56%
PT rev (3m)4.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.67%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.26
P/FCF N/A
P/OCF 5.59
P/B 0.52
P/tB 0.52
EV/EBITDA 8.89
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.45
OCFY17.9%
SpS6.43
BVpS15.65
TBVpS15.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.86%
ROE -1.46%
ROCE 2.56%
ROIC 2.02%
ROICexc 2.05%
ROICexgc 2.05%
OM 10.05%
PM (TTM) N/A
GM 75.69%
FCFM N/A
ROA(3y)-0.61%
ROA(5y)-1.22%
ROE(3y)-1.09%
ROE(5y)-2.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-8.33%
ROICexc growth 3YN/A
ROICexc growth 5Y-8.33%
OM growth 3YN/A
OM growth 5Y-9.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y0.32%
F-Score4
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA 4.77
Cap/Depr 125.71%
Cap/Sales 23.94%
Interest Coverage 1.08
Cash Conversion 77.64%
Profit Quality N/A
Current Ratio 0.49
Quick Ratio 0.49
Altman-Z 0.44
F-Score4
WACC7.06%
ROIC/WACC0.29
Cap/Depr(3y)109.04%
Cap/Depr(5y)101.41%
Cap/Sales(3y)25.78%
Cap/Sales(5y)24.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-425%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.55%
EPS Next Y-1328%
EPS Next 2Y-249.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.69%
Revenue growth 3Y29.01%
Revenue growth 5Y-0.82%
Sales Q2Q%0.5%
Revenue Next Year2.43%
Revenue Next 2Y3.13%
Revenue Next 3Y2.87%
Revenue Next 5YN/A
EBIT growth 1Y-12.17%
EBIT growth 3YN/A
EBIT growth 5Y-10.72%
EBIT Next Year201.89%
EBIT Next 3Y50.29%
EBIT Next 5YN/A
FCF growth 1Y-173.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.62%
OCF growth 3YN/A
OCF growth 5Y-2.38%